Immune Responses Against the Hepatitis C Virus and the Outcome of Therapy

  • Paul Klenerman
  • Eleanor Barnes


Chronic Hepatitis Cell Response Human Leukocyte Antigen Cellular Immune Response Acute Hepatitis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Accapezzato, D., Francavilla, V., Paroli, M., Casciaro, M., Chircu, L.V., Cividini, A., Abrignani, S., Mondelli M.U., Barnaba, V. (2004). Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. Journal of Clinical Investigation 113: 963–972.PubMedCrossRefGoogle Scholar
  2. Barber, D.L., Wherry, E.J., Masopust, D., Zhu, B., Allison, J.P., Sharpe, A.H.,. Freeman, G.H., Ahmed, R. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 439: 682–687.PubMedCrossRefGoogle Scholar
  3. Barnes, E., Harcourt, G., Brown, O., Lucas, M., Phillips, R., Dusheiko, G., Klenerman, P. (2002). The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology, 36: 743–754.PubMedCrossRefGoogle Scholar
  4. Barnes, E., Salio, M., Cerundolo, V., Medlin, J., Murphy, S., Dusheiko, G., Klenerman, P. (2004). Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrobial Agents & Chemotherapy, 48: 3382–3389.CrossRefGoogle Scholar
  5. Boettler, T., Spangenberg, H.C., Neumann-Haefelin, C., Panther, E., Urbani, S.,. Ferrari, C., Blum, H.E., von Weizsacker, F., Thimme, R. (2005). T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. Journal of Virology, 79: 7860–7867.PubMedCrossRefGoogle Scholar
  6. Bowen, D.G., Walker, C.M. (2005). Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. Journal of Experimental Medicine, 201: 1709–1714.PubMedCrossRefGoogle Scholar
  7. Brinkmann, V., Geiger, T., Alkan, S., Heusser, C.H. (1993). Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. Journal of Experimental Medicine , 178: 1655–1663.PubMedCrossRefGoogle Scholar
  8. Brooks, D.G., Trifilo, M.J., Edelmann, K.H., Teyton, L., McGavern, L.B., Oldstone, M.B. (2006). Interleukin-10 determines viral clearance or persistence in vivo. Nature Medicine, 12: 1301–1309.PubMedCrossRefGoogle Scholar
  9. Cooper, S., Erickson, A.L., Adams, E.J., Kansopon, J., Weiner, A.J., Chien, D.Y., Houghton, M., Parham, P., Walker, C.M. (1999). Analysis of a successful immune response against hepatitis C virus. Immunity, 10: 439–449.PubMedCrossRefGoogle Scholar
  10. Cox, A.L., Mosbruger, T., Lauer, G.M., Pardoll, D., Thomas, D.L., Ray, S.C. (2005a). Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology, 42: 104–412.CrossRefGoogle Scholar
  11. Cox, A.L., Mosbruger, T., Mao, Q., Liu, Z., Wang, X.H., Yang, H.C., Sidney, J., Sette, A., Pardoll, D., Thomas, D.L., Ray, S.C. (2005b). Cellular immune selection with hepatitis C virus persistence in humans. Journal of Experimental Medicine, 201: 1741–1752.CrossRefGoogle Scholar
  12. Cramp, M.E., Rossol, S., Chokshi, S., Carucci, P., Williams, R., Naoumov, N.V. (2000). Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology, 118: 346–355.PubMedCrossRefGoogle Scholar
  13. Day, C.L., Kaufmann, D.E., Kiepiela, P., Brown, J.A., Moodley, E.S., Reddy, S., Mackey, E.W., Miller, J.D., Leslie, A.J., DePierres, C., Mncube, Z., Duraiswamy, J.,. Zhu, B., Eichbaum, Q., Altfeld, M., Wherry, E.J., Coovadia, H.M., Goulder, P.J.,. Klenerman, P., Ahmed, R., Freeman, G.J., Walker, B.D. (2006). PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature, 443: 350–354.PubMedCrossRefGoogle Scholar
  14. Day, C.L., Lauer, G.M., Robbins, G.K., McGovern, B., Wurcel, A.G., Gandhi, R.T., Chung, R.T., Walker, B.D. (2002). Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. Journal of Virology, 76: 12584–12595.PubMedCrossRefGoogle Scholar
  15. Diepolder, H., Zachoval, R., Hoffman, R., Wierenga, E., Santorino, T., Jung, M., Eichenlaub, D., Pape, G. (1995). Possible mechanism involving T lymphocyte response to NS3 in viral clearance in acute HCV infection. Lancet, 346: 1006–1007.PubMedCrossRefGoogle Scholar
  16. Erickson, A.L., Kimura, Y., Igarashi, S., Eichelberger, J., Houghton, M., Sidney, J., McKinney, D., Sette, A., Hughes, A.L., Walker, C.M. (2001). The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity, 15: 883–895.PubMedCrossRefGoogle Scholar
  17. Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J.C., Strazzera, A., Chien, A.Y., Munoz, S.J., Balestrieri, A., Purcell, R.H., Alter, H.J. (2000). The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science, 288: 339–344.PubMedCrossRefGoogle Scholar
  18. Fehervari, Z., Sakaguchi, S. (2004). Development and function of CD25+CD4+ regulatory T cells. Current Opinion in Immunology, 16: 203–208.PubMedCrossRefGoogle Scholar
  19. Gaudieri, S., Rauch, A., Park, L.P., Freitas, E., Herrmann, S., Jeffrey, G., Cheng, W.,. Pfafferott, K., Naidoo, K., Chapman, R., Battegay, M., Weber, R., Telenti, A., Furrer, H., James, I., Lucas, M., Mallal, M.S. (2006). Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. Journal of Virology, 80: 11094–11104.PubMedCrossRefGoogle Scholar
  20. Gerlach, J., Diepolder, H., Jung, M.-C., Gruener, N., Schraut, W., Zachoval, R., Hoffman, R., Schirren, C., Santantonio, T., Pape, G. (1999). Recurrence of HCV after loss of virus specific CD4+ T cell response in acute hepatitis C. Gastroenterology, 117: 933–941.PubMedCrossRefGoogle Scholar
  21. Godkin, A. (2001). Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. European Journal of Immunology, 31: 1438–1446.PubMedCrossRefGoogle Scholar
  22. Grabowska, A.M., Lechner, F., Klenerman, P., Tighe, P.J., Ryder, S., Ball, J.K., Thomson, J.K., Irving, W.L., Robins, R.A. (2001). Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. European Journal of Immunology, 31: 2388–2394.PubMedCrossRefGoogle Scholar
  23. Grakoui, A., Shoukry, N.H., Woollard, D.J., Han, J.H., Hanson, H.L., Ghrayeb, J., Murthy, K.K., Rice, C.M.,Walker, C.M. (2003). HCV persistence and immune evasion in the absence of memory T cell help. Science, 302: 659–662.PubMedCrossRefGoogle Scholar
  24. Gruener, N.H., Lechner, F., Jung, M.C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B., Sullivan, J., Phillips, R., Pape, G.R., Klenerman, P. (2001). Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. Journal of Virology, 75: 5550–5558.PubMedCrossRefGoogle Scholar
  25. Harcourt, G., Gomperts, E., Donfield, S., Klenerman, P. (2006). Diminished frequency of hepatitis C virus specific interferon γ secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients. Gut, 55: 1484–1487.PubMedCrossRefGoogle Scholar
  26. Harcourt, G., Hellier, S., Bunce, M., Satsangi, J., Collier, J., Chapman, R., Phillips, R., Klenerman, P. (2001). Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. Journal of Viral Hepatitis, 8: 174–179.PubMedCrossRefGoogle Scholar
  27. Harcourt, G.C., Lucas, M., Godkin, A.J., Kantzanou, M., Phillips, R.E., Klenerman, P. (2003). Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection. Clinical & Experimental Immunology, 131: 122–129.CrossRefGoogle Scholar
  28. Harcourt, G.C., Lucas, M., Sheridan, I., Barnes, E., Phillips, R., Klenerman, P. (2004). Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes. Journal of Viral Hepatitis, 11: 324–331.PubMedCrossRefGoogle Scholar
  29. He, X.-S., Rehermann, B., Lopez-Labrador, F., Boisvert, J., Cheung, R., Mumm, J., Wedermeyer, H., Berenguer, M., Wright, T., Davis, M. (1999). Quantitative analysis of HCV-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. Proceedings of the National Academy of Sciences (USA), 96: 5692–5697.CrossRefGoogle Scholar
  30. Kamal, S.M., Fehr, J., Roesler, B., Peters, T.,Rasenack, J.W. (2002). Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology, 123: 1070–1083.PubMedCrossRefGoogle Scholar
  31. Kamal, S.M., Ismail, A., Graham, C.S., He, W., Rasenack, J.W., Peters, T., Tawil, A.A., Fehr, J.J., Khalifa Kel, S., Madwar, M.M., Koziel, M.J. (2004). Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology, 39: 1721–1731.PubMedCrossRefGoogle Scholar
  32. Kim, A.Y., Lauer, G.M., Ouchi, K., Addo, M.M., Lucas, M., Schulze Zur Wiesch, J.,. Timm, J., Boczanowski, M., Duncan, J.E., Wurcel, A.G., Casson, D., Chung, R.T., Draenert, R., Klenerman, P., Walker, B.D. (2005). The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood, 105: 1170–1178.PubMedCrossRefGoogle Scholar
  33. Klenerman, P., Hill, A. (2005). T cells and viral persistence: lessons from diverse infections. Nature Immunology, 6: 873–879.PubMedCrossRefGoogle Scholar
  34. Koziel, M., Walker, B. (1997). Characteristics of the intrahepatic CTL response in chronic HCV infection. Springer Seminars in Immunopathology, 19: 69–83.PubMedCrossRefGoogle Scholar
  35. Lauer, G., Barnes, E., Lucas, M., Timm, J., Ouchi, K., Kim, A., Day, C., Robbins, G., Casson, D., Reiser, M., Dusheiko, G., Allen, T., Chung, R., Walker, B., Klenerman, P. (2004). High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology, 127: 924–936.PubMedCrossRefGoogle Scholar
  36. Lauer, G. M., Lucas, M., Timm, J., Ouchi, K., Kim, A.Y., Day, C.L., Schulze Zur Wiesch, J., Paranhos-Baccala, G., Sheridan, I., Casson, D.R., Reiser, M., Gandhi, R.T., Li, B., Allen, T.M., Chung, R.T., Klenerman, P., Walker, B.D. (2005). Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. Journal of Virology, 79: 12979–12988.PubMedCrossRefGoogle Scholar
  37. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P.,. Tough, D.F. (2003). Cross-priming of CD8(+) T cells stimulated by virus-induced type I interferon. Nature Immunology 4: 1009–1015.PubMedCrossRefGoogle Scholar
  38. Lechner, F., Gruener, N., Urbani, S., Uggeri, J., Santantonio, T., Cerny, A., Phillips, R., Ferrari, C., Pape, G., Klenerman, P. (2000a). CTL responses are induced during acute HCV infection but are not sustained. European Journal of Immunology, 30: 2479–2487.Google Scholar
  39. Lechner, F., Wong, D.K., Dunbar, P.R., Chapman, R., Chung, R.T., Dohrenwend, P.,. Robbins, G., Phillips, R., Klenerman, P., Walker, B.D. (2000b). Analysis of successful immune responses in persons infected with hepatitis C virus. Journal of Experimental Medicine, 191: 1499–1512.CrossRefGoogle Scholar
  40. Luft, T., Pang, K.C., Thomas, E., Hertzog, P., Hart, D.N., Trapani, J., Cebon, J. (1998). Type I IFNs enhance the terminal differentiation of dendritic cells. Journal of Immunology, 161: 1947–19453.Google Scholar
  41. Marinho, R.T., Pinto, R., Santos, M.L., Lobos, I.V., Moura, M.C. (2004). Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C. Journal of Viral Hepatitis, 11: 206–216.PubMedCrossRefGoogle Scholar
  42. Martin, J., Navas, S., Quiroga, J.A., Pardo, M., Carreno, V. (1998). Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine, 10: 635–644.PubMedCrossRefGoogle Scholar
  43. Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, M., Mori, C., Rumi, M., Houghton, M., Fiaccadori, F., Ferrari, C. (1996). Different clinical behaviours of acute HCV infection are associated with different vigor of the anti-viral T cell response. Journal of Clinical Investigation, 98: 706–714.PubMedCrossRefGoogle Scholar
  44. Moskophidis, D., Laine, E., Zinkernagel, R.M. (1993). Peripheral clonal deletion of antiviral memory CD8+ T cells. European Journal of Immunology, 23: 3306–3311.PubMedCrossRefGoogle Scholar
  45. Plosker, G.L., Keating, G.M. (2004). Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in hepatitis C virus and HIV co-infection. Drugs, 64: 2823–2843.PubMedCrossRefGoogle Scholar
  46. Rahman, F., Heller, T., Sobao, Y., Mizukoshi, E., Nascimbeni, M., Alter, H.,. Herrine, S.,. Hoofnagle, J., Liang, T.J., Rehermann, B. (2004). Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology, 40: 87–97.PubMedCrossRefGoogle Scholar
  47. Rushbrook, S.M., Ward, S.M., Unitt, E., Vowler, S.L., Lucas, M., Klenerman, P.,. Alexander, G.J. (2005). Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. Journal of Virology, 79: 7852–7859.PubMedCrossRefGoogle Scholar
  48. Santini, S.M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., Belardelli, F. (2000). Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. Journal of Experimental Medicine, 191: 1777–1788.PubMedCrossRefGoogle Scholar
  49. Semmo, N., Day, C.L., Ward, S.M., Lucas, M., Harcourt, G., Loughry, A., Klenerman, P. (2005). Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology, 41: 1019–1028.PubMedCrossRefGoogle Scholar
  50. Shoukry, N.H., Grakoui, A., Houghton, M., Chien, D.Y., Ghrayeb, J., Reimann, K.A., Walker, C.M. (2003). Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. Journal of Experimental Medicine , 197: 1645–1655.PubMedCrossRefGoogle Scholar
  51. Sugimoto, K., Ikeda, F., Stadanlick, J., Nunes, F.A., Alter, H.J., Chang, K.M. (2003). Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology, 38: 1437–1448.PubMedGoogle Scholar
  52. Tam, R.C., Pai, B., Bard, J., Lim, C., Averett, D.R., Phan, U.T., Milovanovic, T. (1999). Ribavirin polarizes human T cell responses towards a type 1 cytokine profile. Journal of Hepatology, 30: 376–382.PubMedCrossRefGoogle Scholar
  53. Tang, K.H., Herrmann, E., Cooksley, H., Tatman, N., Chokshi, S., Williams, R., Zeuzem, S., Naoumov, N.V. (2005). Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy. Journal of Hepatology, 43: 776–782.PubMedCrossRefGoogle Scholar
  54. Thursz, M., Yallop, R., Goldin, R., Trepo, C., Thomas, H.C. (1999). Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet, 354: 2119–2124.PubMedCrossRefGoogle Scholar
  55. Timm, J., Lauer, G.M., Kavanagh, D.G., Sheridan, I., Kim, A.Y., Lucas, M., Pillay, T., Ouchi, K., Reyor, L.L., Zur Wiesch, J.S., Gandhi, R.T., Chung, R.T., Bhardwaj, N., Klenerman, P., Walker, B.D., Allen, B.M. (2004). CD8 epitope escape and reversion in acute HCV infection. Journal of Experimental Medicine, 200: 1593–1604.PubMedCrossRefGoogle Scholar
  56. Vertuani, S., Bazzaro, M., Gualandi, G., Micheletti, F., Marastoni, M., Fortini, C., Canella, A., Marino, M., Tomatis, R., Traniello, S., Gavioli, R. (2002). Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals. European Journal of Immunology, 32: 144–54.PubMedCrossRefGoogle Scholar
  57. Ward, S., Lauer, G., Isba, R., Walker, B., Klenerman, P. (2002). Cellular immune responses against hepatitis C virus: the evidence base. Clinical & Experimental Immunology 128: 195–203.CrossRefGoogle Scholar
  58. Wedemeyer, H., He, X.S., Nascimbeni, M., Davis, A.R., Greenberg, H.B., Hoofnagle, J.H., Liang, T.J., Alter, H., Rehermann, B. (2002). Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. Journal of Immunology, 169: 3447–3458.Google Scholar
  59. Wherry, E.J., Ahmed, R. (2004). Memory CD8 T-cell differentiation during viral infection. Journal of Virology, 78: 5535–5545.PubMedCrossRefGoogle Scholar
  60. Zafiropoulos, A., Barnes, E., Piggott, C., Klenerman, P. (2004). Analysis of “driver” and “passenger” CD8+ T-cell responses against variable viruses. Proceedings of the Royal Society B: Biological Sciences 271 Suppl. 3: S53–536.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Paul Klenerman
    • 1
  • Eleanor Barnes
  1. 1.Nuffield Department of MedicinePeter Medawar Building for Pathogen Research, University of OxfordOxfordUK

Personalised recommendations